MeSH D012480 - salmonella infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Ampicillin | Ampicillin Trihydrate |  | 1982-01-01 |  |  |
| Ceftriaxone | Ceftriaxone |  | 2007-03-15 |  |  | |
| Mylan | Ampicillin | Ampicillin Trihydrate |  | 1982-01-01 |  |  |
| GSK | Ampicillin | Totacillin |  | 1982-01-01 |  |  |
| Ampicillin | Totacillin-n |  | 1982-01-01 |  |  | |
| Roche | Ceftriaxone, Lidocaine | Rocephin |  | 1985-03-12 | $261.442 M | Y2021 |
| Lupin Research | Ceftriaxone | Ceftriaxone |  | 2003-09-30 |  |  |
| Sandoz | Ampicillin | Ampicillin |  | 1982-01-01 |  |  |
| Ampicillin, Sulbactam | Ampicillin Sulbactam |  | 2006-07-25 |  |  | |
| Ampicillin | Ampicillin Trihydrate |  | 1995-08-29 |  |  | |
| Ceftriaxone | Ceftriaxone |  | 2005-05-17 |  |  |
1
2
3
4
5
6
...
9
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
0%0/0
Phase 3
100%15/15
Approved: 15Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use